This protocol is judged by an institutional evaluation board, an independent group that reviews any clinical trials involving humans. If a study requires a Agenda I drug, after the board approves the protocol as ethical, the scientists should apply for an investigational new drug (IND) quantity in the FDA. “Now https://brooksqttoh.articlesblogger.com/59620293/the-basic-principles-of-xanax-for-sale